LONDAMOCITINIB
UNII JAC34RRR7S

Substance Identification & Data

This profile provides standardized clinical and technical data for Londamocitinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JAC34RRR7S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2241039-81-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

JAC34RRR7S

CAS Registry Number

2241039-81-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LONDAMOCITINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C28H31F2N7O4S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JNUZADQZHYFJGW-JOCHJYFZSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C203083

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

135240395

Unique identification number in the NCBI database of chemical substances.

INN ID

12630

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-207

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N(C([C@@H](COC)N1CCN(C)CC1)=O)c2c3c(c(c[nH]3)-c4nc(Nc5c(F)c(S(C)(=O)=O)ccc5)ncc4F)ccc2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Londamocitinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LONDAMOCITINIB

Common Names & Synonyms

(R)-N-(3-(5-FLUORO-2-((2-FLUORO-3-(METHYLSULFONYL)PHENYL)AMINO)PYRIMIDIN-4-YL)-1H-INDOL-7-YL)-3-METHOXY-2-(4-METHYLPIPERAZIN-1-YL)PROPANAMIDE

LONDAMOCITINIB [INN]

LONDAMOCITINIB [USAN]

LONDAMOCITINIB [WHO-DD]

Systematic Nomenclature

(2R)-N-(3-(5-FLUORO-2-(2-FLUORO-3-(METHANESULFONYL)ANILINO)PYRIMIDIN-4-YL)-1H-INDOL-7-YL)-3-METHOXY-2-(4-METHYLPIPERAZIN-1-YL)PROPANAMIDE

SYS

1-PIPERAZINEACETAMIDE, N-(3-(5-FLUORO-2-((2-FLUORO-3-(METHYLSULFONYL)PHENYL)AMINO)-4-PYRIMIDINYL)-1H-INDOL-7-YL)-.ALPHA.-(METHOXYMETHYL)-4-METHYL-, (.ALPHA.R)-

SYS